Cortical cholinergic transmission and cortical information processing in schizophrenia.
about
D2-like receptors in nucleus accumbens negatively modulate acetylcholine release in prefrontal cortexPrefrontal acetylcholine release controls cue detection on multiple timescales.Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophreniaAntidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a reviewA dual comparative approach: integrating lines of evidence from human evolutionary neuroanatomy and neurodevelopmental disordersImpaired timing precision produced by striatal D2 receptor overexpression is mediated by cognitive and motivational deficitsAntipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotectionModulation of prepulse inhibition through both M(1) and M (4) muscarinic receptors in miceOxytocin in schizophrenia: a review of evidence for its therapeutic effects.Modulators in concert for cognition: modulator interactions in the prefrontal cortexDifferential role of muscarinic transmission within the entorhinal cortex and basolateral amygdala in the processing of irrelevant stimuli.In vivo evidence for β2 nicotinic acetylcholine receptor subunit upregulation in smokers as compared with nonsmokers with schizophrenia.Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attentionScopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor.Regulation of cortical acetylcholine release: insights from in vivo microdialysis studiesCholinergic enhancement eliminates modulation of neural activity by task difficulty in the prefrontal cortex during working memoryModes and models of forebrain cholinergic neuromodulation of cognition.Role of the central cholinergic system in the therapeutics of schizophrenia.Glutamatergic model psychoses: prediction error, learning, and inferencePro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia.Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy.Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia.Selective effects of cholinergic modulation on task performance during selective attention.Muscarinic receptors modulate the intrinsic excitability of infralimbic neurons and consolidation of fear extinction.Early Life Stress, Nicotinic Acetylcholine Receptors and Alcohol Use Disorders.Towards a muscarinic hypothesis of schizophrenia.Abnormal neurotransmitter release underlying behavioral and cognitive disorders: toward concepts of dynamic and function-specific dysregulation.The effect of prefrontal stimulation on the firing of basal forebrain neurons in urethane anesthetized ratCholinergic circuits and signaling in the pathophysiology of schizophreniaBrain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression.From prediction error to psychosis: ketamine as a pharmacological model of delusions.Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health.A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia.Rats and humans paying attention: cross-species task development for translational researchCNTRICS final task selection: control of attention.From drugs to deprivation: a Bayesian framework for understanding models of psychosis.Disruption of mesolimbic regulation of prefrontal cholinergic transmission in an animal model of schizophrenia and normalization by chronic clozapine treatment.nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms.The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex.
P2860
Q24564769-D958DF02-D09E-43F8-8B89-9FE00A0D1B19Q24674069-3D48E834-AF22-4CBE-A659-E467D10E4D08Q24682717-25B5A336-5C71-45D5-885A-216F780CE07AQ26822244-C854151F-0452-4A41-B336-9705DC833374Q28655504-7A9D2617-221F-4F6F-A151-30905AFAC194Q28749574-F481A565-69F3-410E-B751-C9BA6DCCBFCAQ30386608-3FD9CB33-E7CF-45CC-A46D-5DEDD710BB8DQ30444290-91F54D83-D7EB-4C09-96A0-34C996745003Q30453929-8CEDF07D-1736-4562-960A-7B0A44173FF2Q30493218-C6E1CFB2-3496-4370-B4BC-34538752B162Q30498543-C6A9E574-E905-4DB7-8BE8-E34F6FFA247FQ33605318-81D69CB9-F6BB-41DD-B7B5-2CDFDE999DA1Q33643534-FD48DA7A-9935-4F60-9CD9-5B60E55BAB7BQ33999521-B2E0C3CB-621F-4B6E-8E96-ADD4C0863B5DQ34077418-52929A7A-E7E4-4733-86DF-BEC65C3108B6Q34209512-659B7AB4-9F0E-44A3-BCC9-C42BFA20DD5FQ34355481-6AB4EB15-26EE-4A8D-9ECA-7500FB278E52Q34608625-1555A933-F165-4817-AFD4-CC2BEB3846BCQ34661231-1738B855-302D-49B5-AA27-D4DB0B034D46Q34926526-24EFACDD-080C-47EA-A0FB-C7AD0720D026Q35048154-A3FEFBAA-79FB-4488-88ED-F9095D9F20DBQ35129327-436FD1A5-9C5F-495E-B11A-5C69CE382172Q35390305-F8F4B77C-CA37-4A55-971A-C51A9A8ED750Q35648191-E1F3E609-091C-49CF-BC88-2BAC81785F16Q36100336-5BDA029A-6F76-4217-8F0C-5F8EA21C0D46Q36105732-7086D9FA-2FB1-4D85-8004-A344E2EF3221Q36673957-14E0BB89-0010-494A-B8D4-24742760D4D3Q36681956-9B06674F-B95D-4AEF-89AB-C82CB4FC1E39Q36711377-6522325C-E0CE-48E6-B83F-7C93077AEB08Q36756379-A2B4DDAF-C5BD-4973-AB17-420F4807E608Q36848923-6F5C1869-F96E-4D83-B8FF-9B6073A45A85Q36860032-269BEB06-BBE4-4D51-9530-5AC7D18CD4EBQ37019704-6CCEACEF-5D0C-43A4-BA74-515B6F6EBA1EQ37212798-49AE87A9-BC75-4F45-8F6A-833FC5A6A042Q37249653-C39EF699-7F94-469D-9471-4B5928C932AAQ37346822-457902A0-77AF-4640-8C37-38CE82E04ABDQ37370306-E3B342DB-F421-44FA-BE1D-7F5561946956Q37437840-E651EB44-2ED5-4581-BD99-52C1D7FBEF61Q37465460-59F82EC0-B10B-49CA-A938-7B62955E3E60Q37593550-55CD2555-DBE1-4E7E-87BD-0EA7B6DF8E0C
P2860
Cortical cholinergic transmission and cortical information processing in schizophrenia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cortical cholinergic transmission and cortical information processing in schizophrenia.
@ast
Cortical cholinergic transmission and cortical information processing in schizophrenia.
@en
type
label
Cortical cholinergic transmission and cortical information processing in schizophrenia.
@ast
Cortical cholinergic transmission and cortical information processing in schizophrenia.
@en
prefLabel
Cortical cholinergic transmission and cortical information processing in schizophrenia.
@ast
Cortical cholinergic transmission and cortical information processing in schizophrenia.
@en
P2093
P356
P1476
Cortical cholinergic transmission and cortical information processing in schizophrenia.
@en
P2093
Christopher L Nelson
John P Bruno
Martin Sarter
P304
P356
10.1093/SCHBUL/SBI006
P407
P577
2005-01-01T00:00:00Z